Seed VC · Spain

Ysios Capital

Check size: $1M to $13M

Active

What they invest in

Investing in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need. The management team and strength of science of each venture are key to our investment thesis.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Enterprise

Geography

Europe, US, Global

Recent investments

  • ReproNovo
  • Memo Therapeutics
  • Engrail Therapeutics

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

10 partners on file at Ysios Capital, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Ysios Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Ysios Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Spain
Last known deal
Oct 2016
Website
www.ysioscapital.com/about-us

Other firms investing in DeepTech

See all investors →

Is Ysios Capital the right fit for your deck?

Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Ysios Capital is one of them — and we'll tell you exactly where they sit in your top 100.